Condition: Healthy Volunteers · Pharmacokinetics · Food Effect in Healthy Volunteers · Sponsor: Haiphong University of Medicine and Pharmacy
This is a Phase 1, open-label, single-dose crossover study designed to evaluate the effect of food on the pharmacokinetics of DW-1021, a fixed-dose combination tablet containing pelubiprofen 45 mg and tramadol 45.9 mg. Fourteen healthy adult Vietnamese males will each receive DW-1021 once under fasting conditions and once under fed conditions, with a 14-day washout period in between. Blood samples will be collected to assess how food intake affects the absorption and exposure levels of both active ingredients. Safety, including adverse events, laboratory results, vital signs, and ECGs, will be closely monitored throughout the study.
This description comes directly from the study's public registry record.
Phuong Nguyen Thi Thu Phuong, MD, PhD · +84936685007 · nttphuong@hpmu.edu.vn
Always discuss trial participation with your own doctor first.
| Clinical Trial and Bioequivalence Center | Haiphong, Hai Phong, Vietnam | Recruiting |
| Clinical Trial and Bioequivalence Center | Haiphong, Hai Phong, Vietnam | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07060209